Veterinärmedizinische Universität Wien Forschungsinformationssystem VetDoc

Grafischer Link zur Startseite der Vetmeduni Vienna

Kenner Lukas,

Beiträge für wissenschaftliche Veranstaltungen

Vortrag

Neubauer, HA; Suske, T; Schonefeldt, S; Tangermann, S; Boersma, A; Rulicke, T; Bekiaris, V; Kenner, L; Moriggl, R (2020): The gain-of-function STAT5B(N642H) mutation as a driver of mature T cell leukemia/lymphoma. AACR Annual Meeting, Philadelphia, PA, United States, JUN 22-24, 2020. Cancer Res (80), 16 2752.

Andrukhova, O; Latic, N; Radloff, J; Slavic, S; Endler, L; Murali, S; Bayer, J; Zeitz, U; Pfeiffenberger, U; Tangermann, S; Lagger, S; Wilflingseder, J; Kenner, L; Strobl, B; Erben, R [and 3 others] (2019): FGF23 Promotes Disease Progression in 5/6-Nephrectomized Mice By WNK and Proinflammatory Signaling. Annual Meeting of the American-Society-for-Bone-and Mineral Research, Orlando, FL, United States, SEP 20-23, 2019. J Bone Miner Res (34), S1 57-58.

Neubauer, HA; Suske, T; Pham, HTT; Zahma, S; Tangermann, S; Prchal-Murphy, M; Maurer, B; Sexl, V; Valent, P; Boersma, A; Rülicke, T; Bekiaris, V; Kenner, L; Moriggl, R (2019): The gain of function STAT5B N642H mutation as a driver of mature T-Cell leukemia/lymphoma. Cytokines 2019: 7th Annual Meeting of the International Cytokine & Interferon Society; OCT 20-23, 2019; Vienna, Austria. 2019.

Alonso, IGD; Kothmayer, M; Schlederer, M; Pusch, O; Tangermann, S; Lagger, S; Kenner, L (2018): Examining the function of PDGFRB in anaplastic large cell lymphoma. 6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Rotterdam, Netherlands, SEP 26-29, 2018. Brit J Haematol (182), S1 29-30.

Ducray, SP; Garland, GD; Truong, T; Prokoph, N; Elenitoba-Johnson, KSJ; Lim, MS; Merkel, O; Kenner, L; Bannister, A; Turner, SD (2018): The anaplastic large cell lymphoma (ALCL)-associated nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) directs expression of the nuclear protein brahma related gene 1 (BRG1) driving cell survival. 6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Rotterdam, Netherlands, SEP 26-29, 2018. Brit J Haematol (182), S1 30-30.

Larose, H; Mian, S; Nuglozeh, E; Fazaludeen, FMS; Elmouna, A; Ashankyty, I; Du, MQ; Hoefler, G; Pospisilova, S; Woessmann, W; Damm-Welk, C; Fedorova, A; Lamant, L; Schlederer, M; Merkel, O [and 2 others] (2018): Investigating the functional impact of single nucleotide variants in anaplastic large cell lymphoma. 6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Rotterdam, Netherlands, SEP 26-29, 2018. Brit J Haematol (182), S1 41-42.

Liang, HC; Prutsch, N; Gurnhofer, E; Timelthaler, G; Eferl, R; Tangermann, S; Horvath, J; Stoiber, D; Mathas, S; Kenner, L; Merkel, O (2018): The AP-1-BATF and-BATF3 module: divergent roles in tumour growth, invasion and angiogenesis in anaplastic large cell lymphoma. 6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Rotterdam, Netherlands, SEP 26-29, 2018. Brit J Haematol (182), S1 43-43.

Neubauer, H; Pham, HTT; Suske, T; Spirk, K; Zahma, S; Tangermann, S; Prchal-Murphy, M; Maurer, B; Sexl, V; Valent, P; Boersma, A; Rülicke, T; Kenner, L; Moriggl, R (2018): The role of the gain-of-function STAT5BN642H mutation in the development of leukemia/lymphoma in different hematopoietic lineages. From Receptors and Kinases towards Transcriptional Regulators: Cancer Genome Landscapes and their Therapeutic Targets; MAY 6-9, 2018; Seggau, Stmk, Austria. 2018.

Dillinger, T; Redl, E; Pulverer, W; Sprinzl, B; Hassler, MR; Scheibelreiter, J; Afarani, HS; Kenner, L; Weinhausel, A; Egger, G (2017): Identification of Biomarkers for Prostate Cancer by DNA Methylation Analysis. 1st Global Congress on Molecular Pathology, Berlin, Germany, APR 3-5, 2017. J Mol Diagn (19), 2S S40-S41.

Greiner, G; Witzeneder, N; Berger, A; Schmetterer, K; Eisenworth, G; Schiefer, A; Roos, S; Popow-kraupp, T; Müllauer, L; Zuber, J; Sexl, V; Kenner, L; Sperr, WR; Mayerhofer, M; Valent, P; Hoermann, G (2017): ccl-2 Is A Kit D816v-dependent Modulator Of The Bone Marrow Microenvironment In Systemic Mastocytosis: Cod: T210. Euromedlab 2017 Athen, Athen, Greece, June 11-15, 2017. Clinical Chemistry and Laboratory Medicine (55) 709-709.

Gruber, ES; Birner, P; Merkel, O; Bergmann, M; Schoppmann, SF; Park, J; Moriggl, R; Tse, W; Kenner, L (2017): The coactivator oncogene AF1Q associates with STAT3 activation downstream of MET action in gastro-esophageal cancer patients. AACR, Washington DC, United States, April 1-5, 2017. Cancer Research (70), 13 4463-4463.

Kadletz, L; Kenner, L; Poyntner, L; Formanek, M; Primosch, T; Schartinger, V; Brunner, M (2017): Postoperative radiotherapy versus surgery alone for T1N1 and T2N0 oropharygeal squamous cell carcinoma: a nationwide and retrospective study. ECCO European Cancer Congress, Amsterdam, Netherlands, Jan 27-30, 2017. European Journal Of Cancer (72) 104-104.

Lagger, S (2017): The role of PDGFRB in anaplastic large cell lymphoma. European Research Initiative on ALK Related Malignancies (ERIA) 8th Annual Meeting; Sep 28-29, 2017; Cambridge, United Kingdom. 2017.

Prutsch, N; Sanda, T; Wu, L; Turner, S; Jaeger, U; Staber, P; Steinberger, P; Moriggl, R; Mueller, M; Kenner, L; Merkel, O (2017): The TYK2-STAT1 pathway in aggressive T-Cell Lymphoma: A new therapeutic intervention site? ÖGBMT, Innsbruck, Austria, Sep 25-27, 2017. Oncology Research And Treatment (40) 239-239.

Staber, P; Snijder, B; Vladimer, G; Krall, N; Miura, K; Schmolke, AS; Kornauth, C; Lopez de la Fuente, O; Choi, N; van der Kouwe, E; , Kazianka; Bigenzahn, J; Hoermann, G; Prutsch, N; Merkel, O [and 16 others] (2017): Next-Generation Functional Drug Screening for Patients with Aggressive Hematologic Malignancies. American Society of Hematology, San Diego, United States, Dec 7 2017. Blood (130), 1 855-855.

Hartenbach, M; Baltzer, P; Hartenbach, S; Susani, M; Seitz, C; Kenner, L; Haug, A; Berroter-Infante, N; Wadsak, W; Mitterhauser, M; Pfaff, S; Ponholzer, A; Shariat, S; Hacker, M (2016): Staging primary prostate cancer with 68Ga-PSMA HBED-CC/[18F] Fluorocholine-PET/MRI. Society of Nuclear Medicine, New York, May 2016. Journal of Nuclear Medicine (57), S2 316-316.

Hartenbach, M; Baltzer, P; Hartenbach, S; Susani, M; Seitz, C; Kenner, L; Kramer, G; Haug, A; Berroterán-Infante, N; Wadsak, W; Mitterhauser, M; Pfaff, S; Rausch, I; Ponholzer, A; Shariat, S; Hacker, M (2016): Evaluation of dualtracer multiparametric PET/MRI parameters in primary prostate cancer. Society of Nuclear Medicine, New York, May 1, 2016. Journal of Nuclear Medicine (57), S2 610-610.

Kenner, L; Merkel, O (2016): Neue Aspekte der ALCL Pathogenese. Austrian Society of Hematology and Oncology; März 17-19, 2016; Vienna, Austria. 2016.

Kenner, L; Pencik, J; Hacker, M (2016): Impact of new technologies on malignant tumor management and therapy. EUSAAT 2016, Linz, Austria, AUG 24-27, 2016. AATEX Journal (5), 1 107-107.

Lagger, S; Wodarz, G.; Kuroll, M; Dolznig, H; Egger, G; Turner, S; Jäger, U; Staber, P; Merkel, O; Kenner, L (2016): PDGFRB modulates DNA integrity in anaplastic large cell lymphoma. 8th ÖGMBT Annual Meeting 2016; SEP 12-14, 2016; Graz, AUSTRIA. 2016.

Maurer, B; Nivarthi, H; Prchal-Murphy, M; Wingelhofer, B; Chen, D; Winkler, S; Schlederer, M; Pham, HTT; Kenner, L; Sexl, V; Kolbe, T; Kralovics, R; Muller, M; Rülicke, T; Moriggl, R (2016): Activated Stat5 Drives Peripheral T Cell Lymphomas. 21st Congress of the European-Hematology-Association, Copenhagen, DENMARK, Denmark, JUN 09-12, 2016. Haematologica (101), S1 567-567.

Pencik, J; Schlederer, M; Gruber, W; Unger, C; Walker, SM; Chalaris, A; Marie, IJ; Hassler, MR; Javaheri, T; Aksoy, O; Blayney, JK; Prutsch, N; Skucha, A; Herac, M; Krämer, OH [and 25 others] (2016): IL-6/Stat3 Signaling in Lethal Metastatic Prostate Cancer. 100th Annual Meeting of German Society of Pathology; May 19-22, 2016; Berlin, Germany. 2016.

Pencik, J; Schlederer, M; Gruber, W; Unger, C; Walker, SM; Chalaris, A; Marie, IJ; Hassler, MR; Javaheri, T; Aksoy, O; Blayney, JK; Prutsch, N; Skucha, A; Herac, M; Krämer, OH [and 25 others] (2016): Loss of IL-6/Stat3 Signaling Drives Metastatic Prostate Cancer in Mice and Men. -Keystone Symposium: Cytokine JAK-STAT Signaling in Immunity and Disease; Jan 10-14, 2016; Steamboat Springs, Colorado, USA.

Pencik, J; Schlederer, M; Malcolm, T; Turner, DS; Javaheri, T; Pham, HTT; Moriggl, R; Moazzami, A; Hacker, M; Kenner, L (2016): Metformin-resistance identifies metabolic reprogramming of senescence in cancer. ISREC-SCCL Symposium 2016: Horizons of Cancer Biology and Therapy; Sep 7-10, 2016; Lausanne, Switzerland. 2016.

Prutsch, N; Sanda, T; Turner, S; Wu, L; Müller, M; Jäger, U; Staber, P; Simonitsch-Klupp, I; Alvarez-Hernandez, A; Gurnhofer, E; Suske, T; Grebien, F; Stoiber, D; Schlederer, M; Moriggl, R [and 2 others] (2016): The TYK2-STAT1 pathway in aggressive T-Cell Lymphoma: A novel therapeutic intervention site? -Jahrestagung Österreichische Gesellschaft für Hämatologie und Onkologie (OeGHO); März 17-19, 2016; Vienna, Austria.

Prutsch, N; Sanda, T; Wu, L; Turner, S; Jaeger, U; Staber, P; Steinberger, P; Moriggl, R; Mueller, M; Kenner, L; Merkel, O (2016): The TYK2-STAT1 pathway in aggressive T-Cell Lymphoma: A new therapeutic intervention site. Jahrestagung der ­Deutschen, Österreichischen und ­Schweizerischen ­Gesellschaften für Hämatologie und ­Medizinische Onkologie, Leipzig, Germany, Germany, OCT 14–18, 2016. Oncol Res Treat (39), S3 239-239.

Weber, A; Pencik, J; Kenner, L; Klocker, H; Eder, IE (2016): Switch to succinate-mediated mitochondrial respiration associated with HIF-1 [alpha] stabilization in PTEN negative prostate cancer cells. 11-11.-Androgens Biannual Meeting; SEP 15-17, 2016; Innsbruck.

Fairbairn, C; Malcolm, T; Hughes, K; Kenner, L; Turner, SD (2015): Assessing the origins of anaplastic large cell lymphoma in murine models via forced lineage specificity of NPM-ALK expression in T cells. 5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Varese, ITALY, Italy, OCT 22, 2015. Brit J Haematol (171) 54-54.

Kenner, L; Kuroll, M; Hartmann, T; Krenn, P; Schlederer, M; Prutsch, N; Greil, R; Turner, S; Merkel, O (2015): PGDFR blockade as a novel therapy for NPM-ALK(+) anaplastic large cell lymphoma. 5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Varese, ITALY, Italy, OCT 22, 2015. Brit J Haematol (171) 28-28.

Malcolm, T; Villarese, P; Fairbairn, C; Lamant, L; Trinquand, A; Hook, CE; Burke, GA; Brugieres, L; Hughes, K; Payet, D; Merkel, O; Schiefer, AI; Mian, S; Wasik, M; Turner, M [and 4 others] (2015): NPM-ALK mimics thymic pre-T cell receptor (TCR) expansion but requires transient TCR expression for thymic egress and peripheral anaplastic large cell lymphoma (ALCL) development. 5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Varese, ITALY, Italy, OCT 22, 2015. Brit J Haematol (171) 21-21.

Pencik, J; Schlederer, M; Gruber, W; Unger, C; Walker, SM; Chalaris, A; Marie, I; Hassler, MR; Javaheri, T; Aksoy, O; Blayney, JK; Mazal, P; Grebien, F; Egger, G; Poli, V [and 19 others] (2015): Loss of IL-6/Stat3 signalling drives metastatic prostate cancer in mice and men. 3rd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS), Bamberg, GERMANY, Germany, OCT 11-14, 2015. Cytokine (76), 1 112-112.

Prutsch, N; Sanda, T; Turner, S; Kubicek, S; Boidol, B; Jaeger, U; Simonitsch-Klupp, I; Schiefer, AI; Mueller, M; Wu, L; Kenner, L; Merkel, O (2015): The Tyk2 Pathway as a Novel Therapeutic Intervention Site in Aggressive T-Cell Lymphoma. 20th Congress of European-Hematology-Association, Vienna, AUSTRIA, Austria, JUN 11-14, 2015. Haematologica (100), S1 108-108.

Javaheri, T; Sax, B; Nivarthi, H; Tomazou, E; Mikula, M; Pencik, J; Kazemi, Z; Kauer, M; Wiedner, M; Tuckermann, J; Schlederer, M; Kenner, L; Erben, R; Logan, M; Hartmann, C [and 2 others] (2014): A mouse model for small round cell tumors induced by the Ewing sarcoma oncogene EWS/FLI1. 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), San Diego, CA, United States, APR 05-09, 2014. Cancer Res (74), 19

Kollmann, K; Heller, G; Schneckenleithner, C; Warsch, W; Scheicher, R; Ott, RG; Schäfer, M; Fajmann, S; Schlederer, M; Schiefer, AI; Reichart, U; Mayerhofer, M; Hoeller, C; Zöchbauer-Müller, S; Kerjaschki, D [and 9 others] (2014): A new kinase-independent function of CDK6 links the cell cycle to Tumor surveillance. Joint Symposium between Taiwan-Austrian Research Communities.; MAY 4-11, 2014; Taiwan. 2014.

Kollmann, K; Heller, G; Schneckenleithner, C; Warsch, W; Scheicher, R; Ott, R; Schäfer, M; Fajmann, S; Schlederer, M; Schiefer, AI; Reichart, U; Mayerhofer, M; Hoeller, C; Zoechbauer-Mueller, S; Kerjaschki, D [and 9 others] (2013): A new kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis. -FASEB Science Research Conferences: Hematologic Malignancies; AUG 4-9, 2013; Vermont, USA.

Poster

Ducray, SP; Trigg, R; Bannister, AJ; Lai, R; Egger, G; Merkel, O; Kenner, L; Turner, S (2019): The Identification of Novel Epigenetic Therapies for ALK-Driven Haematological Malignancies. 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Orlando, FL, United States, DEC 07-10, 2019. Blood (134), S1 1483.

Staber, PB; Kornauth, C; Alonso, IGD; Woessmann, W; Klapper, W; Lagger, S; Schiefer, AI; Skrabs, C; Merkel, O; Mayerhoefer, ME; Greil, R; Simonitsch-Klupp, I; Kenner, L; Jaeger, U (2019): Imatinib plus /- Brentuximab Vedotin Induces Sustained Complete Remission in Chemotherapy-Resistant Anaplastic Large Cell Lymphoma Expressing PDGFR. 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Orlando, FL, United States, DEC 07-10, 2019. Blood (134), S1 4037.

Tobias, J; Battin, C; Linhares, AD; Lebens, M; Baier, K; Ambroz, K; Hoegler, S; Inic-Kanada, A; Garner-Spitzer, E; Preusser, M; Kenner, L; Kundi, M; Zielinski, CC; Steinberger, P; Wiedermann, U (2019): Active immunization with immune checkpoint inhibitors-mimotope elicits strong anti-tumour effect against HER-2/neu-expressing tumours. 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, SEP 27-OCT 01, 2019. Ann Oncol (30), S5 480-480.

Lagger, S; Hagelkruys, A; Ramsahoye, BH; Schöfer, C; Kenner, L; Schweikert, G; Connelly, J; Bird, A; Seiser, C (2018): Investigating DNA methylation distribution and function in the mouse brain. 2018 Max Planck Freiburg Epigenetics Meeting; DEC 5-8, 2018; Freiburg, Germany. 2018.

Balber, T; Aksoy, O; Merkel, O; Kenner, L; Hartenbach, M; Berroteran-Infante, N; Wadsak, W; Hacker, M; Mitterhauser, M (2017): In vitro uptake of [F-18]FEC, [I-125]T3 and [C-14]Testosterone in CRYM-overexpressing prostate cancer cell lines. 22nd International Symposium on Radiopharmaceutical Sciences (ISRS 2017), Dresden, Germany, May 14‐19, 2017. J Labelled Compd Rad (60), S1 S192-S192.

Maurer, B; Pham, HTT; Prchal-Murphy, M; Nivarthi, H; Wingelhofer, B; Schlederer, M; Grausenburger, R; Winkler, S; Halbritter, F; Farlik, M; Bock, C; Kenner, L; Kolbe, T; Rülicke, T; Müller, M [and 2 others] (2017): Graded STAT5A or STAT5B activity promote T-cell neoplasia. STATs: Importance In Basic & Clinical Cancer Research; Nov 15-18, 2017; Cold Spring Harbor, United States (USA). 2017.

Shirsath, N; Wagner, K; Ober, J; Mayer, G; Schlederer, M; Roos, S; Kenner, L; Wolf, P (2017): PUVA diminishes imiquimod-induced psoriatic phenotype with gene expression signature associated with senescence. 47th Annual Meeting of the European-Society-for-Dermatological-Research (ESDR), Salzburg, AUSTRIA, Austria, SEP 27-30, 2017. J Invest Dermatol (137), 10 S301-S301.

Aksoy, O; Merkel, O; Susani, M; Hassler, M; Schlangen, K; Balber, T; Mitterhauser, M; Moazzami, A; Schlederer, M; Turner, S; Egger, G; Hörmann, G; Hartenbach, M; Hartenbach, S; Hacker, M [and 3 others] (2016): NADPH-Regulated Thyroid-Hormone Binding Protein as Hormone Antagonist in Prostate Cancer. LBG Meeting for Health Sciences; NOV 28-29, 2016; Vienna, Austria. 2016.

Aufinger, A; Rauscher, B; Schlederer, M; Hassler, M; Vollheim, K; Pencik, J; Limberger, T; Walker, S; Kennedy, R; Aberger, F; Gruber, W; Mathas, S; Egger, G; Dolznig, H; Morrigl, R [and 2 others] (2016): Loss of c-Jun enhances tumor formation in a mouse model of prostate cancer. LBG Meeting for Health Sciences (Vienna); NOV 28-29, 2016; Vienna, Austria. 2016.

Crncec, I; Gordziel, C; Pathria, P; Modak, M; Stöckl, J; Wallner, B; Strobl, B; Leitner, N; Müller, M; Rauch, I; Decker, T; Schlederer, M; Kenner, L; Friedrich, K; Eferl, R (2016): The role of STAT1 in colitis-associated colorectal cancer. -Bridge Gaps Cross Roads - Joint Symposium of 4 PhD programs - CCHD, IAI, ICA, MCCA; FEB 1-3, 2016; Vienna, AUSTRIA.

Garces, I; Lagger, S; Wodarz, G; Kuroll, M; Dolznig, H; Egger, G; Turner, S; Jäger, U; Staber, P; Merkel, O; Kenner, L (2016): Examining the function of PDGFRB in anaplastic large cell lymphoma. 7th Meeting of the European Research Initiative on ALK-Related Malignancies (ERIA) ; SEP 27-28, 2016; Vienna, Austria. 2016.

Garces, I; Wodarz, G; Lagger, S; Roos, S; Kenner, L (2016): PDGFRB function in anaplastic large cell lymphoma. LBG Meeting for Health Sciences ; NOV 28-29, 2016; Vienna, Austria. 2016.

Hagiwara, S; Mine, S; Schiefer, AI; Kenner, L; Tse, W (2016): High expression of AF1Q is an adverse prognostic factor and a prediction marker of extramedullary disease in multiple myeloma. 21st Congress of the European-Hematology-Association, Copenhagen, DENMARK, Denmark, JUN 09-12, 2016. Haematologica (101), S1 530-530.

Limberger, T; Schlederer, M; Pencik, J; Aufinger, A; Kenner, L (2016): Oncogenic role of Kmt2c in prostate cancer. LBG Meeting for Health Sciences (Vienna); NOV 28-29, 2016; Vienna, Austria. 2016.

Malcolm, T; Fairbairn, CJ; Hughes, K; Kenner, L; Burke, A; Turner, S (2016): Assessing the origins of anaplastic large cell lymphoma in murine models via forced lineage specificity of NPM-ALK expression in T cells. American Association for Cancer Research, New Orelans, April 16-20, 2016. Cancer Research (76), 14 671-671.

Merkel, O; Aksoy, O; Suzani, M; Hassler, M; Schlangen, K; Balber, T; Mitterhauser, M; Moazzami, A; Schlederer, M; Turner, S; Egger, G; Hormann, G; Hacker, M; Culig, Z; Pencik, J; Kenner, L (2016): μ-Crystalline as hormone antagonist in prostate cancer. 7-7.-Androgens Biannual Meeting; SEP 15-17, 2016; Innsbruck.

Merkel, O; Prutsch, N; Gurnhofer, E; Bian, W; Slabicki, M; Schmatz, A; Turner, S; Kenner, L (2016): Role of the AP-1 transcription factor BATF/BATF3 in Anaplastic Large Cell Lymphoma. Austrian Society of Hematology and Oncology; März 17-19, 2016; Vienna, Austria. 2016.

Pencik, J; Schlederer, M; Malcolm, T; Turner, DS; Javaheri, T; Pham, HTT; Moriggl, R; Moazzami, A; Hacker, M; Kenner, L (2016): Metformin-resistance identifies metabolic reprogramming of senescence in cancer. -Annual LBI-CR SAB Meeting; NOV 28-29, 2016; Vienna, Austria.

Hagiwara, S; Schiefer, AI; Mine, S; Kenner, L; Tse, W (2015): High Expression of AF1q Is an Adverse Prognostic Factor in Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation. 55th Annual Meeting and Exposition of the American-Society-of-Hematology, New Orleans, LA, DEC 07-10, 2013. Blood (126), 23

Maurer, B; Nivarthi, H; Prchal-Murphy, M; Wingelhofer, B; Chen, D; Winkler, S; Prochazkova, J; Schlederer, M; Pham, H; Loizou, JI; Kenner, L; Sexl, V; Kolbe, T; Kralovics, R; Müller, M [and 2 others] (2015): An activating STAT5 mutation is sufficient for Peripheral T Cell Lymphoma formation. 3rd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS), Bamberg, GERMANY, Germany, OCT 11-14, 2015. Cytokine (76), 1 77-77.

Hainzl, E; Rauch, I; Heider, S; Kenner, L; Decker, T; Strobl, B; Müller, M (2011): Tyrosine kinase 2 protects from chemically-induced colitis via amplification of interleukin-22 signalling. 9th Joint Meeting of the International-Cytokine-Society/International-Society-for-Interferon-and-Cytokine-Research, Florence, ITALY, Italy, OCT 09-12, 2011. Cytokine (56), S1 32-32.

Hainzl, E; Rauch, I; Heider, S; Kenner, L; Decker, T; Strobl, B; Müller, M (2011): Tyrosine kinase 2 protects from chemically-induced colitis via amplification of interleukin-22 signalling. -9th Joint Meeting of the ICS/ISICR; Okt 9-12, 2011; Florence, Italy.

Kenner, L; Laimer, D; Dolznig, H; Vesely, P; Kollmann, K; Schiefer, AII; Sexl, V; Staber, PB; Hoefler, G; Penninger, J; Inghirami, G; Ulrich, J (2011): New and Highly Efficient Therapy for Treatment NPM-ALK Associated Lymphomas. 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, San Diego, CA, United States, DEC 10-13, 2011. Blood (118), 21 721-721.

Nivarthi, H; Tsyrulnyk, A; Warsch, W; Wang, ZQ; Winkler, S; Kenner, L; Müller, M; Baum, C; Bunting, KD; Sexl, V; Rülicke, T; Moriggl, R (2011): Generation of a Transgenic Mouse with Inducible Constitutively Active Stat5a. 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, San Diego, CA, United States, DEC 10-13, 2011. Blood (118), 21 1456-1456.

Rauch, I; Hainzl, E; Heider, S; Strobl, B; Müller, M; Kenner, L; Decker, T (2011): Type I Interferons interfere with resolving inflammation of DSS induced acute colonic disease. -Microbiota and mucosal immunology: The interface in health and disease; April 14-16, 2011; San Francisco USA.

© Veterinärmedizinische Universität Wien Hilfe und DownloadsErklärung zur Barrierefreiheit